EPISODE · Jul 30, 2025 · 25 MIN
The FDA's Gene-Therapy Reversal and the Exit of Vinay Prasad
from WSJ Opinion: Potomac Watch · host Paul Gigot, The Wall Street Journal
A top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this episode say about the Trump Administration's approach toward drug development and innovation? Plus, Robert F. Kennedy Jr. says he plans to overhaul the National Vaccine Injury Compensation Program. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Embed this episode
What this episode covers
A top official at the Food and Drug Administration steps down after the agency changes course on a treatment for Duchenne muscular dystrophy. What does this episode say about the Trump Administration's approach toward drug development and innovation? Plus, Robert F. Kennedy Jr. says he plans to overhaul the National Vaccine Injury Compensation Program.
Ready to play
The FDA's Gene-Therapy Reversal and the Exit of Vinay Prasad
No transcript for this episode yet
Similar Episodes
No similar episodes found.